title: Minimization of administration route errors with subcutaneous rituximab.
authors.affiliation: European Institute of Oncology, Milan, Italy sarah.liptrott@ieo.it.
authors.forename: Sarah
authors.initials: S
authors.lastname: Liptrott
authors.affiliation: F. Hoffmann-La Roche Ltd, Basel, Switzerland.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Cambon
authors.affiliation: F. Hoffmann-La Roche Ltd, Basel, Switzerland.
authors.forename: Natalia
authors.initials: N
authors.lastname: Berthillon
authors.affiliation: F. Hoffmann-La Roche Ltd, Basel, Switzerland.
authors.forename: Maria
authors.initials: M
authors.lastname: Mendoza
authors.affiliation: F. Hoffmann-La Roche Ltd, Basel, Switzerland.
authors.forename: Rodney
authors.initials: R
authors.lastname: Smith
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D055104:Infusions, Subcutaneous / Q000379:methods; D000069283:Rituximab / Q000008:administration & dosage*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab